The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Molecular and Clinical Epidemiology of CXCR4‐Using HIV‐1 in a Large Population of Antiretroviral‐Naive Individuals
Open accessAbstract
OBJECTIVE: We wished to characterize the epidemiological and clinical correlates of CXCR4-using human immunodeficiency virus type 1 (HIV-1) ("X4 variants") in a cross-sectional analysis of a large population of antiretroviral-naive individuals. METHODS: HIV-1 coreceptor use was determined in the last pretherapy plasma sample for 1191 individuals initiating triple-combination therapy in British Columbia, Canada. Baseline variables investigated included sociodemographic characteristics, plasma viral load (pVL), CD4 cell count, AIDS diagnosis, HIV-1 V3 loop sequence, and human CCR5 Delta 32 genotype. RESULTS: Individuals harboring X4 variants (n = 178 of 979 phenotyped samples; 18.2%) displayed a poorer baseline clinical profile than individuals harboring exclusively CCR5-using HIV-1 ("R5 variants") (median pVL, 175,000 vs. 120,000 copies of HIV-1 RNA/mL [P = .0006]; median CD4 cell count, 110 vs. 290 cells/mm(3) [P < .0001]). Individuals heterozygous for the CCR5 Delta 32 deletion (n = 128 of 967; 13.2%) were at 2.5 times higher risk of harboring X4 variants, compared with those without the deletion (multivariate P = .0005). The presence of basic amino acids at codon 11 and/or codon 25 of HIV-1 V3 (n = 109 of 955; 11.4%) was associated with a 9.1 times higher risk of harboring X4 variants (multivariate P < .0001), regardless of CCR5 Delta 32 genotype. In multivariate analyses adjusting for baseline parameters, HIV-1 coreceptor use was not found to be a significant predictor of survival or treatment response. CONCLUSION: Baseline CD4 cell count, pVL, HIV-1 V3 sequence, and CCR5 Delta 32 genotype were the strongest determinants of CXCR4-using HIV-1 in this population. After adjustment for baseline parameters, the presence of X4 variants before initiation of highly active antiretroviral therapy was not independently associated with a poorer outcome of therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor
Feng, Y., Broder, C. C., Kennedy, P. E., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5263.872 · Cited by 4,172
Identification of a major co-receptor for primary isolates of HIV-1
Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Marzio, P. D., Marmon, S., Sutton, R. E., Hill, C. M., et al. (1996) · Nature · doi:10.1038/381661a0 · Cited by 3,641
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
Dragic, T., Litwin, V., Allaway, G. P., Martin, S. R., Huang, Y., Nagashima, K. A., Cayanan, C., Maddon, P. J., Koup, R. A., Moore, J. P., et al. (1996) · Nature · doi:10.1038/381667a0 · Cited by 3,174
CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1
Alkhatib, G., Combadiere, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, P. M., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5270.1955 · Cited by 2,706
Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Smith, M. W., Allikmets, R., Goedert, J. J., Buchbinder, S. P., Vittinghoff, E., Gomperts, E., et al. (1996) · Science · doi:10.1126/science.273.5283.1856 · Cited by 2,484
Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease
Berger, E. A., Murphy, P. M., & Farber, J. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.657 · Cited by 2,180
Schuitemaker, H., Koot, M., Kootstra, N. A., Dercksen, M. W., de Goede, R. E., van Steenwijk, R. P., Lange, J. M., Schattenkerk, J. K., Miedema, F., & Tersmette, M. (1992) · Journal of Virology · doi:10.1128/jvi.66.3.1354-1360.1992 · Cited by 1,032
A new classification for HIV-1
Berger, E. A., Doms, R. W., Fenyö, E.-M., Korber, B. T. M., Littman, D. R., Moore, J. P., Sattentau, Q. J., Schuitemaker, H., Sodroski, J., & Weiss, R. A. (1998) · Nature · doi:10.1038/34571 · Cited by 830
Koot, M., Keet, I. P. M., Vos, A. H. V., de Goede, R. E. Y., Roos, M. T. L., Coutinho, R. A., Miedema, F., Schellekens, P. T. A., & Tersmette, M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-9-199305010-00004 · Cited by 785
Hogg, R. S. (2001) · JAMA · doi:10.1001/jama.286.20.2568 · Cited by 728
Self-citationCCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro
Wu, L., Paxton, W. A., Kassam, N., Ruffing, N., Rottman, J. B., Sullivan, N., Choe, H., Sodroski, J., Newman, W., Koup, R. A., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1681 · Cited by 694
Tersmette, M., Gruters, R. A., de Wolf, F., de Goede, R. E., Lange, J. M., Schellekens, P. T., Goudsmit, J., Huisman, H. G., & Miedema, F. (1989) · Journal of Virology · doi:10.1128/jvi.63.5.2118-2125.1989 · Cited by 636
Moore, J. P., Kitchen, S. G., Pugach, P., & Zack, J. A. (2004) · AIDS Research and Human Retroviruses · doi:10.1089/088922204322749567 · Cited by 494
The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression
Michael, N. L., Chang, G., Loum, L. G., Mascola, J. R., Dondero, D., Birx, D. L., & Sheppard, H. W. (1997) · Nature Medicine · doi:10.1038/nm0397-338 · Cited by 448
Jensen, M. A., Li, F.-S., van ’t Wout, A. B., Nickle, D. C., Shriner, D., He, H.-X., McLaughlin, S., Shankarappa, R., Margolick, J. B., & Mullins, J. I. (2003) · Journal of Virology · doi:10.1128/jvi.77.24.13376-13388.2003 · Cited by 428
Hogg, R. S., Heath, K., Bangsberg, D., Yip, B., Press, N., O'Shaughnessy, M. V., & Montaner, J. S. G. (2002) · AIDS · doi:10.1097/00002030-200205030-00012 · Cited by 425
Self-citationRichman, D. D., & Bozzette, S. A. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.5.968 · Cited by 401
Schuitemaker, H., Kootstra, N. A., de Goede, R. E., de Wolf, F., Miedema, F., & Tersmette, M. (1991) · Journal of Virology · doi:10.1128/jvi.65.1.356-363.1991 · Cited by 324
Hughes, M. D., Johnson, V. A., Hirsch, M. S., Bremer, J. W., Elbeik, T., Erice, A., Kuritzkes, D. R., Scott, W. A., Spector, S. A., Basgoz, N., et al. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-12-199706150-00001 · Cited by 280
Association between CCR5 Genotype and the Clinical Course of HIV-1 Infection
de Roda Husman, A.-M., Koot, M., Cornelissen, M., Keet, I. P. M., Brouwer, M., Broersen, S. M., Bakker, M., Roos, M. T. L., Prins, M., de Wolf, F., et al. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-10-199711150-00004 · Cited by 267
Connor, R. I., & Ho, D. D. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4400-4408.1994 · Cited by 259
Eugen-Olsen, J., Iversen, A. K. N., Garred, P., Koppelhus, U., Pedersen, C., Benfield, T. L., Sorensen, A. M., Katzenstein, T., Dickmeiss, E., Gerstoft, J., et al. (1997) · AIDS · doi:10.1097/00002030-199703110-00007 · Cited by 234
Epidemiology and Predictive Factors for Chemokine Receptor Use in HIV‐1 Infection
Moyle, G. J., Wildfire, A., Mandalia, S., Mayer, H., Goodrich, J., Whitcomb, J., & Gazzard, B. G. (2005) · The Journal of Infectious Diseases · doi:10.1086/428096 · Cited by 230
Self-citationResch, W., Hoffman, N., & Swanstrom, R. (2001) · Virology · doi:10.1006/viro.2001.1087 · Cited by 202
Mosier, D. E., Picchio, G. R., Gulizia, R. J., Sabbe, R., Poignard, P., Picard, L., Offord, R. E., Thompson, D. A., & Wilken, J. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3544-3550.1999 · Cited by 182
Zhang, Y., Dragic, T., Cao, Y., Kostrikis, L. G., Kwon, D. S., Littman, D. R., KewalRamani, V. N., & Moore, J. P. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.9337-9344.1998 · Cited by 152
Simple determination of human immunodeficiency virus type 1 syncytium-inducing V3 genotype by PCR
Fouchier, R. A. M., Brouwer, M., Broersen, S., et al. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.4.906-911.1995 · Cited by 118
Brumme, Z. L., Dong, W. W. Y., Yip, B., Wynhoven, B., Hoffman, N. G., Swanstrom, R. I., Jensen, M. A., Mullins, J. I., Hogg, R. S., Montaner, J. S. G., et al. (2004) · AIDS · doi:10.1097/00002030-200403050-00001 · Cited by 94
Self-citationGlushakova, S. E., Yi, Y., Grivel, J., Singh, A., Schols, D., Clercq, E. D., Collman, R. G., & Margolis, L. B. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7403 · Cited by 91
Bozzette, S. A., McCutchan, J. A., Spector, S. A., Wright, B. C., & Richman, D. D. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/168.6.1374 · Cited by 91
Co-receptor antagonists as HIV-1 entry inhibitors
Shaheen, F., & Collman, R. G. (2004) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200402000-00003 · Cited by 81
Willey, S. J., Reeves, J. D., Hudson, R., Miyake, K., Dejucq‐Rainsford, N., Schols, D., Clercq, E. D., Bell, J. E., McKnight, Á., & Clapham, P. R. (2003) · Journal of Virology · doi:10.1128/jvi.77.11.6138-6152.2003 · Cited by 55
D’Aquila, R. T., Sutton, L., Savara, A. V., Hughes, M. D., & Johnson, V. A. (1998) · The Journal of Infectious Diseases · doi:10.1086/515307 · Cited by 30
Furrer, H., Wendland, T., Minder, C. E., Christen, A., von Overbeck, J., Grunow, R., Pichler, W. J., & Malinverni, R. (1998) · AIDS · doi:10.1097/00002030-199811000-00016 · Cited by 20
Cited by
Bioinformatics prediction of HIV coreceptor usage
Lengauer, T., Sander, O., Sierra, S., Thielen, A., & Kaiser, R. (2007) · Nature Biotechnology · doi:10.1038/nbt1371 · Cited by 343
Westby, M., Lewis, M., Whitcomb, J., Youle, M., Pozniak, A. L., James, I. T., Jenkins, T. M., Perros, M., & van der Ryst, E. (2006) · Journal of Virology · doi:10.1128/jvi.80.10.4909-4920.2006 · Cited by 337
Predictors of disease progression in HIV infection: a review
Langford, S. E., Ananworanich, J., & Cooper, D. A. (2007) · AIDS Research and Therapy · doi:10.1186/1742-6405-4-11 · Cited by 337
HIV-1 drug resistance and resistance testing
Clutter, D. S., Jordan, M. R., Bertagnolio, S., & Shafer, R. W. (2016) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2016.08.031 · Cited by 333
HIV-1 Antiretroviral Resistance: Scientific Principles and Clinical Applications
Tang, M. W., & Shafer, R. W. (2012) · Drugs · doi:10.2165/11633630-000000000-00000 · Cited by 326
Metadata
- Authors
- Brumme, Z. L., Goodrich, J., Mayer, H. B., Brumme, C. J., Henrick, B. M., Wynhoven, B., Asselin, J. J., Cheung, P. K., Hogg, R. S., Montaner, J. S. G., & Harrigan, P. R.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-08
- Volume
- 192
- Issue
- 3
- Pages
- 466-474
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2172198911
- Cited by
- 270
- References
- 34
- FWCI
- 7.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.